Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

NCT03108456 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03108456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03108456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 27, 2017
Completion date
June 12, 2025
Enrollment
2,005 (actual)
Sites
104

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, ischemic heart disease, non st segment elevation myocardial infarction